floxuridine has been researched along with Lymphoproliferative Disorders in 1 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Lymphoproliferative Disorders: Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Fragile sites expression induced by 5-fluorodeoxyuridine (FudR) or 5-bromodeoxyuridine (BrdU) was analyzed in 4 healthy individuals and 4 patients affected with lymphoproliferative disorders: one Hodgkin's disease, one mycosis fungoides and two chronic lymphoproliferative disorders." | 3.68 | [Expression of new fragile sites detected in lymphoproliferative processes]. ( Fundia, AF; Larripa, IB; Slavutsky, IR, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fundia, AF | 1 |
| Slavutsky, IR | 1 |
| Larripa, IB | 1 |
1 other study available for floxuridine and Lymphoproliferative Disorders
| Article | Year |
|---|---|
[Expression of new fragile sites detected in lymphoproliferative processes].
Topics: Bromodeoxyuridine; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human; Floxuridine; | 1990 |